Assessment of PPG & PAT to Detect Upper Airway Obstruction in Patients With Obstructive Sleep Apnea
Not Applicable
- Conditions
- Sleep Apnea, Obstructive
- Interventions
- Device: Measurement of PPG waveformsDevice: Measurement of Pulse Arrival Time (PAT)
- Registration Number
- NCT01831583
- Lead Sponsor
- Sotera Wireless, Inc.
- Brief Summary
The goal of this study is to collect raw waveform data for two separate noninvasive methods, both of which may be useful for the assessment of upper airway obstruction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Patients twenty-one years of age or older
Exclusion Criteria
- Patient refusal to participate in study
- Patients under 21 (twenty-one) years of age,
- Referring physician's refusal to have his/her patient participate in the study.
- Patients with cardiac dysrhythmia (arrhythmia), including atrial fibrillation, and frequent premature atrial and/or ventricular contractions.
- Inability to obtain a Sotera cuff pressure and/or PPG signals
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Measurement of PPG waveforms Measurement of PPG waveforms Collection of photoplethysmograph(PPG)waveform data from patients with obstructive sleep apnea for 4-8 hours Measurement of Pulse Arrival Time (PAT) Measurement of Pulse Arrival Time (PAT) Collection of PAT waveform data from patients with obstructive sleep apnea for 4-8 hours
- Primary Outcome Measures
Name Time Method Measurement of pulse arrival time in patients with obstructive sleep apnea syndrome. 4 - 8 hours The goal of this study is to collect pulse arrival time data as a means for the assessment of upper airway obstruction.
- Secondary Outcome Measures
Name Time Method Non-invasive Photoplethysmographic (PPG) measurement in patients with obstructive sleep apnea syndrome. 4 - 8 hours The goal of this study is to collect PPG waveforms as a means for the assessment of upper airway obstruction.
Trial Locations
- Locations (1)
Palomar Hospital
🇺🇸Escondido, California, United States